Surgery comparison for advanced stomach cancer after initial surgery
Part of Cancer, Digestive system clinical trials.
This trial studies whether removing all of the fatty lining (omentum) or only part of it during surgery leads to better outcomes in people with advanced stomach cancer. It also checks that participants can safely have the same stomach-cancer chemotherapy plan after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had stomach cancer surgery called D2 R0 resection, with lymph nodes removed showing at least 16 nodes, and no remaining visible tumor (R0).
- You are healthy enough to tolerate another abdominal surgery, based on your overall physical condition and organ test results.
- You are between 18 and 70 years old, and your stomach cancer diagnosis is confirmed by pathology (lab testing).
- You must be able to sign consent and follow the study plan for the full study period.
- You must not have had chemotherapy or radiation before joining, and you must be able to take 8 cycles of XELOX chemotherapy after surgery.
- Your tumor stage must fit specific limits (T3 to T4a, no distant spread), and the tumor must not be on the greater curvature.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares having surgery to remove stomach cancer versus not having surgery in patients whose cancer in the abdominal lining responded well to initial treatment. The goal is to see which approach helps patients live longer and feel better.
This trial compares removing part or all of the fatty lining of the stomach (omentum) during minimally invasive surgery for a certain stage of gastric cancer. The goal is to see if removing less tissue is as safe and effective.
This study compares two ways surgeons reconnect the digestive tract after removing the whole stomach for certain stomach cancers near the esophagus. It aims to see which technique is safer and leads to better recovery and outcomes.
This trial tests if surgery to remove the stomach and some tumors, after a few months of chemo, helps people whose stomach cancer has spread to only a few nearby spots (like the lining of the belly, liver, or lymph nodes) live longer compared to chemo alone.
This trial compares two ways surgeons remove the entire stomach (total gastrectomy): laparoscopic (small keyhole cuts) versus open surgery (one larger cut). It’s testing which approach is safer and works better for people with certain stages of stomach cancer.
This trial compares two laparoscopic surgeries for early-stage stomach cancer in the upper part of the stomach. It looks at whether preserving a nerve (celiac branch of vagus nerve) during surgery leads to better recovery while still removing the cancer safely.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.